Provided by Tiger Trade Technology Pte. Ltd.

Agios Pharmaceuticals

31.87
-0.0500-0.16%
Volume:410.11K
Turnover:13.08M
Market Cap:1.90B
PE:-4.55
High:32.15
Open:31.85
Low:31.53
Close:31.92
52wk High:46.00
52wk Low:22.24
Shares:59.47M
Float Shares:50.09M
Volume Ratio:0.34
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.0075
EPS(LYR):-7.1203
ROE:-34.34%
ROA:-22.24%
PB:1.85
PE(LYR):-4.48

Loading ...

Agios Gets EU Approval for Pyrukynd in Thalassemia

MT Newswires Live
·
May 22

Agios says EU approves PYRUKYND for adults with alpha- or beta-thalassemia anemia

Reuters
·
May 22

Agios’ Pyrukynd® (Mitapivat) Approved in the European Union for Adults With Thalassemia

THOMSON REUTERS
·
May 22

Analysts Are Bullish on These Healthcare Stocks: Actuate Therapeutics, Inc. (ACTU), Agios Pharma (AGIO)

TIPRANKS
·
May 13

Agios Pharmaceuticals to present mitapivat data at EHA Congress

TIPRANKS
·
May 13

Agios Pharmaceuticals Submits Supplemental New Drug Application to FDA for Mitapivat

MT Newswires Live
·
May 12

Agios submits FDA sNDA for accelerated approval of mitapivat in sickle cell disease

Reuters
·
May 12

Agios says mitapivat Phase 3 RISE UP trial boosts hemoglobin in sickle cell disease

Reuters
·
May 12

Agios Pharmaceuticals Inc - Expects Snda Filing Acceptance Notice in Q3 2026

THOMSON REUTERS
·
May 12

Agios Submits Snda to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

THOMSON REUTERS
·
May 12

RBC Capital Sticks to Its Hold Rating for Agios Pharma (AGIO)

TIPRANKS
·
May 01

Agios Pharmaceuticals Is Maintained at Buy by Truist Securities

Dow Jones
·
Apr 30

Agios publishes 2025 annual report

Reuters
·
Apr 30

Agios Pharmaceuticals announces annual shareholder meeting webcast details

Reuters
·
Apr 30

Stock Track | Agios Pharmaceuticals Soars 9.68% Intraday on Strong Q1 Revenue Beat and Successful Drug Launch

Stock Track
·
Apr 29

Stock Track | Agios Pharmaceuticals Soars 6.07% in Pre-Market on Strong Q1 Earnings Beat

Stock Track
·
Apr 29

Agios Q1 FY26 net loss widens to $99.1 million; net product revenue rises to $18.8 million

Reuters
·
Apr 29

Earnings Flash (AGIO) Agios Pharmaceuticals Posts Q1 Net Loss $1.69 a Share, vs. FactSet Est of $1.80 Loss

MT Newswires Live
·
Apr 29

Biopharma firm Agios Q1 product revenue more than doubles, beats estimates

Reuters
·
Apr 29

Agios Pharmaceuticals Q1 EPS $(1.69) Beats $(1.79) Estimate, Sales $20.746M Beat $13.646M Estimate

Benzinga Earnings
·
Apr 29